Nipah virus emergence, transmission, and pathogenesis

Global Virology I-Identifying and Investigating Viral Diseases

Volumn , Issue , 2015, Pages 125-146

  De Wit, Emmie ^a   Munster, Vincent J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Emerging virus infection; Henipavirus; Natural reservoir; Nipah virus; Pathogenesis; Transmission

Indexed keywords

EID: 84944527153     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-2410-3_7     Document Type: Chapter

References (122)

1. Centers for Disease C, Prevention. Outbreak of Hendra-like virus - Malaysia and Singapore, 1998-1999. MMWR Morb Mortal Wkly Rep. 1999;48:265-9.
2. Mohd Nor MN, Gan CH, Ong BL. Nipah virus infection of pigs in peninsular Malaysia. Rev Sci Tech. 2000;19:160-5.
3. Centers for Disease C, Prevention. Update: outbreak of Nipah virus - Malaysia and Singapore, 1999. MMWR Morb Mortal Wkly Rep. 1999;48:335-7.
4. Parashar UD, Sunn LM, Ong F, Mounts AW, Arif MT, et al. Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999outbreak of severe encephalitis in Malaysia. J Infect Dis. 2000;181:1755-9.
5. Tan KS, Tan CT, Goh KJ. Epidemiological aspects of Nipah virus infection. Neurol J S E Asia. 1999;4:77-81.
6. Paton NI, Leo YS, Zaki SR, Auchus AP, Lee KE, et al. Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet. 1999;354:1253-6.
7. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, et al. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000;288:1432-5.
8. Mounts AW, Kaur H, Parashar UD, Ksiazek TG, Cannon D, et al. A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus, Malaysia, 1999. J InfectDis. 2001;183:810-3.
9. Tan CT, Tan KS. Nosocomial transmissibility of Nipah virus. J Infect Dis. 2001;184:1367.
10. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis. 2006;12:235-40.
11. Arankalle VA, Bandyopadhyay BT, Ramdasi AY, Jadi R, Patil DR, et al. Genomic characterization of Nipah virus, West Bengal, India. Emerg Infect Dis. 2011;17:907-9.
12. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, et al. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis. 2004;10:2082-7.
13. Icddr B. Outbreaks of encephalitis due to Nipah/Hendra-like viruses, Western Bangladesh. Health Sci Bull. 2003;1:1-6.
14. Icddr B. Nipah encephalitis outbreak over wide area of Western Bangladesh, 2004. Health Sci Bull. 2004;2:7-11.
15. ICDDRB. Person-to-person transmission of Nipah virus during outbreak in Faridpur District, 2004. Health Sci Bull. 2004;2:5-9.
16. Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, et al. Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis. 2006;12:1888-94.
17. Homaira N, Rahman M, Hossain MJ, Epstein JH, Sultana R, et al. Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007. Epidemiol Infect.2010;138:1630-6.
18. Homaira N, Rahman M, Hossain MJ, Nahar N, Khan R, et al. Cluster ofNipah virus infection, Kushtia District, Bangladesh, 2007. PLoS One. 2010;5:e13570.
19. Icddr B. Nipah outbreak in Lalmonirhat district, 2011. Health Sci Bull. 2011;9:13-8.
20. ICDDRB. Person-to-person transmission of Nipah virus infection in Bangladesh, 2007.Health Sci Bull. 2007;5:1-6.
21. Lo MK, Lowe L, Hummel KB, Sazzad HM, Gurley ES, et al. Characterization of nipah virus from outbreaks in bangladesh, 2008-2010. Emerg Infect Dis. 2012;18:248-55.
22. Rahman MA, Hossain MJ, Sultana S, Homaira N, Khan SU, et al. Date palm sap linked to nipah virus outbreak in Bangladesh, 2008. Vector Borne Zoonotic Dis. 2011;12:65.
23. Sazzad HM, Hossain MJ, Gurley ES, Ameen KM, Parveen S, et al. Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh. Emerg Infect Dis.2013;19:210-7.
24. Khan MS, Hossain J, Gurley ES, Nahar N, Sultana R, et al. Use of infrared camera to understand bats’ access to date palm sap: implications for preventing Nipah virus transmission. Ecohealth. 2010;7:517-25.
25. Luby SP, Hossain MJ, Gurley ES, Ahmed BN, Banu S, et al. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis. 2009;15:1229-35
26. Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, et al. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis. 2007;13:1031-7.
27. Chong HT, Hossain J, Tan CT. Differences in epidemiologic and clinical features of Nipahvirus encephalitis between the Malaysian and Bangladesh outbreaks. Neurol Asia. 2008;13:23-6.
28. de Wit E, Bushmaker T, Scott D, Feldmann H, Munster VJ. Nipah virus transmission in a hamster model. PLoS Negl Trop Dis. 2011;5:e1432.
29. Debuysscher BL, de Wit E, Munster VJ, Scott D, Feldmann H, et al. Comparison of the pathogenicity of nipah virus isolates from bangladesh and Malaysia in the Syrian hamster.PLoS Negl Trop Dis. 2013;7:e2024.
30. de Wit E, Prescott J, Falzarano D, Bushmaker T, Scott D, et al. Foodborne transmission of Nipah virus in Syrian hamsters. PLoS Pathog. 2014;10:e1004001.
31. Marsh GA, de Jong C, Barr JA, Tachedjian M, Smith C, et al. Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog. 2012;8:e1002836.
32. Young PL, Halpin K, Selleck PW, Field H, Gravel JL, et al. Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg InfectDis. 1996;2:239-40.
33. Yob JM, Field H, Rashdi AM, Morrissy C, van der Heide B, et al. Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. Emerg Infect Dis. 2001;7:439-41.
34. Chua KB, Koh CL, Hooi PS, Wee KF, Khong JH, et al. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect. 2002;4:145-51.
35. Reynes JM, Counor D, Ong S, Faure C, Seng V, et al. Nipah virus in Lyle’s flying foxes, Cambodia. Emerg Infect Dis. 2005;11:1042-7.
36. Olson JG, Rupprecht C, Rollin PE, An US, Niezgoda M, et al. Antibodies to Nipah-like virus in bats (Pteropus lylei), Cambodia. Emerg Infect Dis. 2002;8:987-8.
37. Wacharapluesadee S, Lumlertdacha B, Boongird K, Wanghongsa S, Chanhome L, et al. Bat Nipah virus, Thailand. Emerg Infect Dis. 2005;11:1949-51.
38. Yadav PD, Raut CG, Shete AM, Mishra AC, Towner JS, et al. Detection of Nipah virus RNA in fruit bat (Pteropus giganteus) from India. Am J Trop Med Hyg. 2012;87:576-8.
39. Wacharapluesadee S, Boongird K, Wanghongsa S, Ratanasetyuth N, Supavonwong P, et al.A longitudinal study of the prevalence of Nipah virus in Pteropus lylei bats in Thailand:evidence for seasonal preference in disease transmission. Vector Borne Zoonotic Dis.2010;10:183-90.
40. Sendow I, Field HE, Curran J, Darminto, Morrissy C, et al. Henipavirus in Pteropus vampyrus bats, Indonesia. Emerg Infect Dis. 2006;12:711-2.
41. Sendow I, Field HE, Adjid A, Ratnawati A, Breed AC, et al. Screening for Nipah virus infection in West Kalimantan Province, Indonesia. Zoonoses Public Health. 2010;57:499-503.
42. Epstein JH, Prakash V, Smith CS, Daszak P, McLaughlin AB, et al. Henipavirus infection infruit bats (Pteropus giganteus), India. Emerg Infect Dis. 2008;14:1309-11.
43. Hasebe F, Thuy NT, Inoue S, Yu F, Kaku Y, et al. Serologic evidence of nipah virus infection in bats, Vietnam. Emerg Infect Dis. 2012;18:536-7.
44. Field H, de Jong CE, Halpin K, Smith CS. Henipaviruses and fruit bats, Papua New Guinea. Emerg Infect Dis. 2013;19:670-1.
45. Breed AC, Meers J, Sendow I, Bossart KN, Barr JA, et al. The distribution of henipaviruses in Southeast Asia and Australasia: is Wallace’s line a barrier to Nipah virus? PLoS One.2013;8:e61316.
46. Breed AC, Yu M, Barr JA, Crameri G, Thalmann CM, et al. Prevalence of henipavirus and rubu-lavirus antibodies in Pteropid Bats, Papua New Guinea. Emerg Infect Dis. 2010;16:1997-9.
47. Smith CS, Epstein JH, Breed AC, Plowright RK, Olival KJ, et al. Satellite telemetry andlong-range bat movements. PLoS One. 2011;6:e14696.
48. Breed AC, Field HE, Smith CS, Edmonston J, Meers J. Bats without borders: long-distance movements and implications for disease risk management. Ecohealth. 2010;7:204-12.
49. Hahn MB, Gurley ES, Epstein JH, Islam MS, Patz JA, et al. The role of landscape composition and configuration on pteropus giganteus roosting ecology and nipah virus spillover risk in Bangladesh. Am J Trop Med Hyg. 2014;90:247-55.
50. Daszak P, Zambrana-Torrelio C, Bogich TL, Fernandez M, Epstein JH, et al. Interdisciplinary approaches to understanding disease emergence: the past, present, and future drivers of Nipahvirus emergence. Proc Natl Acad Sci U S A. 2013;110 Suppl 1:3681-8.
51. Pulliam JR, Epstein JH, Dushoff J, Rahman SA, Bunning M, et al. Agricultural intensification, priming for persistence and the emergence of Nipah virus: a lethal bat-borne zoonosis. J R Soc Interface. 2012;9:89-101.
52. Plowright RK, Field HE, Smith C, Divljan A, Palmer C, et al. Reproduction and nutritional stress are risk factors for Hendra virus infection in little red flying foxes (Pteropus scapula-tus). Proc Biol Sci. 2008;275:861-9.
53. Plowright RK, Foley P, Field HE, Dobson AP, Foley JE, et al. Urban habituation, ecological connectivity and epidemic dampening: the emergence of Hendra virus from flying foxes(Pteropus spp.). Proc Biol Sci. 2011;278:3703-12.
54. Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, et al. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop Med Hyg. 2011;85:946-51.
55. Middleton DJ, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, et al. Experimental Nipah virus infection in pteropid bats (Pteropus poliocephalus). J Comp Pathol. 2007;136:266-72.
56. Sendow I, Ratnawati A, Taylor T, Adjid RM, Saepulloh M, et al. Nipah virus in the fruit bat pteropus vampyrus in Sumatera, Indonesia. PLoS One. 2013;8:e69544.
57. Drexler JF, Corman VM, Gloza-Rausch F, Seebens A, Annan A, et al. Henipavirus RNA in African bats. PLoS One. 2009;4:e6367.
58. Hayman DT, Suu-Ire R, Breed AC, McEachern JA, Wang L, et al. Evidence of henipavirus infection in West African fruit bats. PLoS One. 2008;3:e2739.
59. Iehle C, Razafitrimo G, Razainirina J, Andiiaholinirina N, Goodman SM, et al. Henipavirus and Tioman virus antibodies in pteropodid bats, Madagascar. Emerg Infect Dis. 2007;13:159-61.
60. Peel AJ, Baker KS, Crameri G, Barr JA, Hayman DT, et al. Henipavirus neutralising antibodies in an isolated island population of African fruit bats. PLoS One. 2012;7:e30346.
61. Drexler JF, Corman VM, Muller MA, Maganga GD, Vallo P, et al. Bats host major mammalian paramyxoviruses. Nat Commun. 2012; 3.
62. Chong HT, Kunjapan SR, Thayaparan T, Tong J, Petharunam V, et al. Nipah encephalitis outbreak in Malaysia, clinical features in patients from Seremban. Can J Neurol Sci. 2002;29:83-7.
63. Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000;342:1229-35.
64. Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999;354:1257-9.
65. Lee KE, Umapathi T, Tan CB, Tjia HT, Chua TS, et al. The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus. Ann Neurol. 1999;46:428-32.
66. Sarji SA, Abdullah BJ, Goh KJ, Tan CT, Wong KT. MR imaging features of Nipah encephalitis. AJR Am J Roentgenol. 2000;175:437-42.
67. Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, et al. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis inMalaysia. J Infect. 2001;42:40-3.
68. Chua KB, Lam SK, Tan CT, Hooi PS, Goh KJ, et al. High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid. Ann Neurol. 2000;48:802-5.
69. Hossain MJ, Gurley ES, Montgomery JM, Bell M, Carroll DS, et al. Clinical presentation ofnipah virus infection in Bangladesh. Clin Infect Dis. 2008;46:977-84.
70. Abdullah S, Chang LY, Rahmat K, Goh KJ, Tan CT. Late-onset Nipah virus encephalitis 11 years after the initial outbreak: a case report. Neurol Asia. 2012;17:71-4.
71. Sejvar JJ, Hossain J, Saha SK, Gurley ES, Banu S, et al. Long-term neurological and functional outcome in Nipah virus infection. Ann Neurol. 2007;62:235-42.
72. Tan CT, Goh KJ, Wong KT, Sarji SA, Chua KB, et al. Relapsed and late-onset Nipah encephalitis. Ann Neurol. 2002;51:703-8.
73. Wong SC, Ooi MH, Wong MN, Tio PH, Solomon T, et al. Late presentation of Nipah virus encephalitis and kinetics of the humoral immune response. J Neurol Neurosurg Psychiatry.2001;71:552-4.
74. Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, et al. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol. 2002;161:2153-67.
75. Middleton DJ, Westbury HA, Morrissy CJ, van der Heide BM, Russell GM, et al. ExperimentalNipah virus infection in pigs and cats. J Comp Pathol. 2002;126:124-36.
76. Weingartl H, Czub S, Copps J, Berhane Y, Middleton D, et al. Invasion of the central nervous system in a porcine host by nipah virus. J Virol. 2005;79:7528-34.
77. Wong KT, Grosjean I, Brisson C, Blanquier B, Fevre-Montange M, et al. A golden hamster model for human acute Nipah virus infection. Am J Pathol. 2003;163:2127-37.
78. Rockx B, Brining D, Kramer J, Callison J, Ebihara H, et al. Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. J Virol.2011;85:7658-71.
79. Munster VJ, Prescott JB, Bushmaker T, Long D, Rosenke R, et al. Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route. Sci Rep. 2012;2:736.
80. Mathieu C, Pohl C, Szecsi J, Trajkovic-Bodennec S, Devergnas S, et al. Nipah virus usesleukocytes for efficient dissemination within a host. J Virol. 2011;85:7863-71.
81. Yoneda M, Guillaume V, Sato H, Fujita K, Georges-Courbot MC, et al. The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals.PLoS One. 2010;5:e12709.
82. Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, et al. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virusinfection. PLoS Pathog. 2009;5:e1000642.
83. Clayton BA, Middleton D, Bergfeld J, Haining J, Arkinstall R, et al. Transmission routes for nipah virus from Malaysia and Bangladesh. Emerg Infect Dis. 2012;18:1983-93.
84. Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, et al. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoSOne. 2010;5:e10690.
85. Marianneau P, Guillaume V, Wong T, Badmanathan M, Looi RY, et al. Experimental infection of squirrel monkeys with nipah virus. Emerg Infect Dis. 2010;16:507-10.
86. Hooper P, Zaki S, Daniels P, Middleton D. Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect. 2001;3:315-22.
87. Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, et al. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J Virol.2006;80:12293-302.
88. Mungall BA, Middleton D, Crameri G, Halpin K, Bingham J, et al. Vertical transmission and fetal replication of Nipah virus in an experimentally infected cat. J Infect Dis. 2007;196:812-6.
89. Dhondt KP, Mathieu C, Chalons M, Reynaud JM, Vallve A, et al. Type I interferon signaling protects mice from lethal henipavirus infection. J Infect Dis. 2013;207:142-51.
90. Nahar N, Sultana R, Gurley ES, Hossain MJ, Luby SP. Date palm sap collection: exploring opportunities to prevent Nipah transmission. Ecohealth. 2010;7:196-203.
91. Nahar N, Mondal UK, Sultana R, Hossain MJ, Khan MS, et al. Piloting the use of indigenous methods to prevent Nipah virus infection by interrupting bats’ access to date palm sap inBangladesh. Health Promot Int. 2012;28:378-86.
92. Khan SU, Gurley ES, Hossain MJ, Nahar N, Sharker MA, et al. A randomized controlled trial of interventions to impede date palm sap contamination by bats to prevent nipah virus transmission in Bangladesh. PLoS One. 2012;7:e42689.
93. Blum LS, Khan R, Nahar N, Breiman RF. In-depth assessment of an outbreak of Nipah encephalitis with person-to-person transmission in Bangladesh: implications for preventionand control strategies. Am J Trop Med Hyg. 2009;80:96-102.
94. Snell NJ. Ribavirin - current status of a broad spectrum antiviral agent. Expert Opin Pharmacother. 2001;2:1317-24.
95. Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, et al. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001;49:810-3.
96. Freiberg AN, Worthy MN, Lee B, Holbrook MR. Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.J Gen Virol. 2010;91:765-72.
97. Georges-Courbot MC, Contamin H, Faure C, Loth P, Baize S, et al. Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob AgentsChemother. 2006;50:1768-72.
98. Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, et al. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.J Virol. 2010;84:9831-9.
99. Guillaume V, Contamin H, Loth P, Georges-Courbot MC, Lefeuvre A, et al. Nipah virus: vaccination and passive protection studies in a hamster model. J Virol. 2004;78:834-40.
100. Guillaume V, Contamin H, Loth P, Grosjean I, Courbot MC, et al. Antibody prophylaxis andtherapy against Nipah virus infection in hamsters. J Virol. 2006;80:1972-8.
101. Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, et al. Exceptionally potent crossreactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J Infect Dis. 2008;197:846-53.
102. Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, et al. A neutralizing human monoclonal antibody protects African green monkeys from hendra virus challenge. SciTransl Med. 2011;3:105ra103.
103. Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, et al. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res. 2013;100:8-13.
104. Pallister J, Middleton D, Crameri G, Yamada M, Klein R, et al. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets. J Virol. 2009;83:11979-82.
105. Porotto M, Rockx B, Yokoyama CC, Talekar A, Devito I, et al. Inhibition of Nipah virusinfection in vivo: targeting an early stage of paramyxovirus fusion activation during viralentry. PLoS Pathog. 2010;6:e1001168.
106. Elshabrawy HA, Fan J, Haddad CS, Ratia K, Broder CC, et al. Identification of a broad-spectrum antiviral small molecule against SARS-CoV, Ebola, Hendra, and Nipah viruses using a novelhigh throughput screening assay. J Virol. 2014;88:4353.
107. Liu SY, Aliyari R, Chikere K, Li G, Marsden MD, et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity. 2013;38:92-105.
108. Porotto M, Yi F, Moscona A, LaVan DA. Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus. PLoS One. 2011;6:e16874.
109. Aljofan M, Lo MK, Rota PA, Michalski WP, Mungall BA. Off label antiviral therapeutics for henipaviruses: new light through old windows. J Antivir Antiretrovir. 2010;2:1-10.
110. Weingartl HM, Berhane Y, Caswell JL, Loosmore S, Audonnet JC, et al. Recombinant nipahvirus vaccines protect pigs against challenge. J Virol. 2006;80:7929-38.
111. Chattopadhyay A, Rose JK. Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach. J Virol. 2011;85:2004-11.
112. Lo MK, Bird BH, Chattopadhyay A, Drew CP, Martin BE, et al. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrianhamsters. Antiviral Res. 2014;101:26-9.
113. Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, et al. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virol J.2013;10:353.
114. Ploquin A, Szecsi J, Mathieu C, Guillaume V, Barateau V, et al. Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines. J Infect Dis.2013;207:469-78.
115. Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, et al. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah viruschallenge. PLoS One. 2013;8:e58414.
116. Defang GN, Khetawat D, Broder CC, Quinnan Jr GV. Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivoexpression system. Vaccine. 2010;29:212-20.
117. Kong D, Wen Z, Su H, Ge J, Chen W, et al. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Virology. 2012;432:327-35.
118. McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, et al. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine. 2008;26:3842-52.
119. Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, et al. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Sci Transl Med.2012;4:146ra107.
120. Pallister JA, Klein R, Arkinstall R, Haining J, Long F, et al. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus diseasefor over 12 months. Virol J. 2013;10:237.
121. Walpita P, Barr J, Sherman M, Basler CF, Wang L. Vaccine potential of Nipah virus-like particles. PLoS One. 2011;6:e18437.
122. Wang X, Ge J, Hu S, Wang Q, Wen Z, et al. Efficacy of DNA immunization with F and G protein genes of Nipah virus. Ann N Y Acad Sci. 2006;1081:243-5.